Jun Ishigooka
4PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 05, 2024
Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning.Jun Ishigooka, Kazuyuki Nakagome, Tetsuro Ohmori
|Oct 09, 2021
Discontinuation and remission rates and social functioning in patients with schizophrenia receiving second-generation antipsychotics: 52-week evaluation of JUMPs, a randomized, open-label study.Jun Ishigooka, Kazuyuki Nakagome, Tetsuro Ohmori
|Sep 17, 2021
Patient and Physician Perspectives of Depressive Symptoms and Expectations for Treatment Outcome: Results from a Web-Based Survey.Jun Ishigooka, Tatsuya Hoshino, Takumi Imai
|Dec 29, 2019
Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study.Nakao Iwata, Jun Ishigooka, Ichiro Naoi
Pageof 1
Frequent Collaborators
1 joint publications
Nakao Iwata
1 joint publications
Ichiro Naoi
1 joint publications
Masahiro Matsumoto
1 joint publications
Yuichi Kanamori
1 joint publications
Hiroshi Nakamura
1 joint publications
Teruhiko Higuchi
1 joint publications
Tatsuya Hoshino
1 joint publications
Takumi Imai
1 joint publications
Hisako Yoshida
1 joint publications
Midori Ono
